Concord Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Concord Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Buy	+311	New	+$174K	0.02%	237
2026 Q1	–	Sell	-311	Closed	-$210K	–	469
2025 Q4	$210K	Hold	311	–	–	0.03%	190
2025 Q3	$199K	Hold	311	–	–	0.03%	192
2025 Q2	$167K	Hold	311	–	–	0.02%	218
2025 Q1	$131K	Sell	311 -2	-0.6%	-$868	0.02%	222
2024 Q4	$129K	Hold	313	–	–	0.02%	230
2024 Q3	$158K	Buy	313 +2	+0.6%	+$972	0.03%	222
2024 Q2	$152K	Hold	311	–	–	0.03%	218
2024 Q1	$168K	Hold	311	–	–	0.03%	223
2023 Q4	$173K	Hold	311	–	–	0.03%	215
2023 Q3	$136K	Hold	311	–	–	0.03%	242
2023 Q2	$156K	Hold	311	–	–	0.03%	217
2023 Q1	$156K	Hold	311	–	–	0.04%	194
2022 Q4	$127K	Buy	+311	New	+$121K	0.04%	214
2022 Q3	–	Sell	-311	Closed	-$109K	–	603
2022 Q2	$109K	Sell	311 -7	-2%	-$2.85K	0.03%	250
2022 Q1	$174K	Buy	318 +7	+2%	+$3.68K	0.05%	198
2021 Q4	$205K	Buy	+311	New	+$195K	0.05%	183
2021 Q3	–	Sell	-311	Closed	-$196K	–	959
2021 Q2	$196K	Sell	311 -3	-1%	-$1.66K	0.06%	138
2021 Q1	$154K	Buy	+314	New	+$157K	0.05%	156

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Concord Wealth Partners's IDXX Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 311 shares worth $164K. The stake represents 0.02% of the portfolio and ranks #237 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in IDXX as recently as Q4 2025.

Concord Wealth Partners first reported a position in IDXX in Q1 2021 and has held it in 19 quarters since. The position peaked at $210K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Concord Wealth Partners held 311 shares of Idexx Laboratories worth $164K as of Q2 2026.
Idexx Laboratories was a new Concord Wealth Partners position in Q2 2026.
Idexx Laboratories made up 0.02% of Concord Wealth Partners's portfolio in Q2 2026, its #237 holding.
Concord Wealth Partners first reported a position in Idexx Laboratories in Q1 2021 and has held it in 19 quarters since.
Concord Wealth Partners's Idexx Laboratories position peaked at $210K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.